Log In
Print this Print this

ketoconazole AID-SCFM

  Manage Alerts
Collapse Summary General Information
Company Agenzia Industrie Difesa Stabilimento Chimico Farmaceutico Militare
Description200 mg oral formulation of an imidazole derivative that inhibits cytochrome P450 17 alpha-hydroxylase/C17, 20 lyase (CYP17; CYP17A), an enzyme involved in cortisol synthesis
Molecular Target Cytochrome P450 17 alpha-hydroxylase/C17, 20 lyase (CYP17) (CYP17A)
Mechanism of ActionCytochrome P450 17alpha-hydroxylase/C17,20 lyase (CYP17) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationCushing's disease
Indication DetailsTreat Cushing's syndrome
Regulatory Designation EU - Orphan Drug (Treat Cushing's syndrome)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today